PT  - JOURNAL ARTICLE
AU  - Yoko Otake
AU  - Thomas Walle
TI  - Oxidation of the Flavonoids Galangin and Kaempferide by Human Liver Microsomes and CYP1A1, CYP1A2, and CYP2C9
AID  - 10.1124/dmd.30.2.103
DP  - 2002 Feb 01
TA  - Drug Metabolism and Disposition
PG  - 103--105
VI  - 30
IP  - 2
4099  - http://dmd.aspetjournals.org/content/30/2/103.short
4100  - http://dmd.aspetjournals.org/content/30/2/103.full
SO  - Drug Metab Dispos2002 Feb 01; 30
AB  - There is very limited information on cytochrome P450 (P450)-mediated oxidative metabolism of dietary flavonoids in humans. In this study, we used human liver microsomes and recombinant P450 isoforms to examine the metabolism of two flavonols, galangin and kaempferide, and one flavone, chrysin. Both galangin and kaempferide, but not chrysin, were oxidized by human liver microsomes to kaempferol, with Km values of 9.5 and 17.8 μM, respectively. These oxidations were catalyzed mainly by CYP1A2 but also by CYP2C9. Consistent with these observations, the human liver microsomal metabolism of galangin and kaempferide were inhibited by the P450 inhibitors furafylline and sulfaphenazole. In addition, CYP1A1, although less efficient, was also able to oxidize the two flavonols. Thus, dietary flavonols are likely to undergo oxidative metabolism mainly in the liver but also extrahepatically. The American Society for Pharmacology and Experimental Therapeutics